Takeda Pharma in three year research pact with Envoy
Under the contarct, using Envoy’s proprietary bacTRAP technology, its scientists will identify proteins that are selectively expressed in specific cell types within the brain that are known to
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
AstraZeneca and Pozen have co-developed Vimovo, which is a fixed-dose combination of enteric-coated naproxen, a pain-relieving NSAID and immediate-release esomeprazole, a proton pump inhibitor (PPI). Vimovo is indicated
Sanofi Pasteur said that the contract supported by the HHS Biomedical Advanced Research and Development Authority (BARDA) affords rapid response and production of a strain-matched pandemic influenza vaccine